Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. (ACAD) — Form 8-K: Current report
About this filing
Acadia Pharmaceuticals Inc. (ACAD) filed an 8-K on Sep 24, 2026 reporting a Regulation FD disclosure (Item 7.01) and other events (Item 8.01), with exhibits (Item 9.01).
Key facts
- Item 7.01 · Regulation FD disclosure
- Item 8.01 · Other events
- Item 9.01 · Financial statements and exhibits
More ACAD filings
- 4
Filed Oct 30, 2026
- 8-K
Filed Oct 23, 2026
- 8-K
Filed Sep 11, 2026
- 4
Filed Aug 7, 2026
- SC 13G
Filed Aug 7, 2026
- 144
Filed Aug 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.